In Depth 30 May 2024
Covalent biologics: a new class of drugs on the horizon
The field of covalent biologics has made headway recently, as the only biotech in the space has bagged $100 million to move its pipeline to the clinic.
Research
- Latest Posts
Podcast 24 May 2024
How biotech is tackling myasthenia gravis
To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion.
Expert Advice 26 Apr 2024
Biotech career: What it’s really like being a research assistant
Labiotech spoke to Elina Kuznecova, a research assistant at the University of Oxford, to find out about what the role of a research assistant entails.
Best in Biotech 22 Mar 2024
6 biotechnology universities in the UK leading the way for future talent
Discover the pinnacle of biotechnology education in the UK with our article to the top universities offering cutting-edge programs.
Best in Biotech 8 Mar 2024
Eight biotechnology universities in Germany cultivating future leaders
Explore Germany’s top biotechnology universities! Uncover where tomorrow’s leaders are trained, bridging science with market success.
Protein inhibitors: cracking the code of disease mechanisms
Explore how protein inhibitors revolutionize disease understanding, by unlocking the secrets of disease pathways.
ADVERTISEMENT
ADVERTISEMENT
In Depth 26 Jan 2024
Long COVID: are we on the verge of a breakthrough?
Studies and recent developments in long COVID research could pave the way for more diagnostic and therapeutic opportunities.
News and Trends 12 Jan 2024
AI and a brain organoid: can this combo take on supercomputers?
Explore the groundbreaking fusion of brain organoids and AI in the creation of Brainoware, the world’s first biohybrid computer.
Best in Biotech 11 Jan 2024
Ten NK cell therapy companies to look out for this year
As biotechs raise funding to advance their NK cell therapy candidates in the clinic, here are ten companies in the space to watch out for.
Weekly Roundup 15 Dec 2023
Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered
What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.
Weekly Roundup 8 Dec 2023
Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer
What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.
News and Trends 1 Dec 2023
Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered
Here is Labiotech’s weekly roundup of the latest biotech news. Stay in the loop by subscribing to our newsletter for direct updates to your inbox. The latest biotech news in fundraising In the news this week, biotech Arvinas raises $350 million PIPE American protein degradation company Arvinas has bagged $350 million in a private placement (PIPE). The […]
ADVERTISEMENT
